BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
DDOG
Datadog, Inc.
DDOG has the edge over BAC overall, supported by stronger valuation and stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
DDOG Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
DDOG's revenue, profitability, cash flow and balance sheet are all currently healthy.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
DDOG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 62x | $184 | — |
| Cheap | 251x | $181 | -2.1% |
| Current | 256x | $184 | — |
| Fair | 379x | $273 | +48% |
| Expensive | 621x | $447 | +142% |
Historical ranges are pointers, not guarantees.
DDOG has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over DDOG on the outlook, with more favorable profitability expectations.
DDOG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Broad | |
| Low |
Analysts expect strong earnings and revenue growth for DDOG, with profitability holding steady. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over DDOG on earnings, with more consistent year-over-year improvement.
DDOG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.99 | +315% |
| Q3 2026 | $0.72 | +125% |
| Q2 2026 | $0.50 | +39% |
| Q1 2026 | $0.39 | -17% |
| Q4 2025 | $0.31 | -40% |
| Q3 2025 | $0.32 | -42% |
| Q2 2025 | $0.36 | -23% |
| Q1 2025 | $0.47 | +38% |
| Q4 2024 | $0.52 | +271% |
DDOG earned $0.72 per share over the past year, up 125% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over DDOG on profitability, with a higher operating margin.
DDOG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +35% |
| Q2 2026 | $1.1B | +36% |
| Q1 2026 | $1B | +32% |
| Q4 2025 | $953.2M | +29% |
| Q3 2025 | $885.7M | +28% |
| Q2 2025 | $826.8M | +28% |
| Q1 2025 | $761.6M | +25% |
| Q4 2024 | $737.7M | +25% |
DDOG has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.2% | +6.9 points |
| Q2 2026 | 0.5% | +4.8 points |
| Q1 2026 | 0.7% | +2.4 points |
| Q4 2025 | 1% | -0.3 points |
| Q3 2025 | -0.7% | -3.6 points |
| Q2 2025 | -4.3% | -6.3 points |
| Q1 2025 | -1.6% | -3.6 points |
| Q4 2024 | 1.3% | -3.4 points |
DDOG's operating margin was 6.2% last quarter, up 6.9 points from the same quarter a year ago, near the top of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
DDOG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $279.1M | +19% |
| Q2 2026 | $306M | +65% |
| Q1 2026 | $323.3M | +23% |
| Q4 2025 | $318.2M | +24% |
| Q3 2025 | $234.7M | +6.5% |
| Q2 2025 | $184.9M | +16% |
| Q1 2025 | $262.8M | +33% |
| Q4 2024 | $257.5M | +23% |
DDOG has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over DDOG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
DDOG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +4M shares |
| 1 year | +3.6% | +13M shares |
| 3 years | +6.7% | +23.7M shares |
| 5 years | +21% | +64.8M shares |
| Available history | +14% | +47.2M shares |
DDOG has 375M diluted shares, up 3.6% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
DDOG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 7.0x | High |
| Q1 2026 | 18.2x | High |
| Q4 2025 | 123.2x | High |
| Q3 2025 | 94.8x | High |
| Q2 2025 | 16.5x | High |
| Q1 2025 | 6.9x | High |
| Q4 2024 | 3.6x | Elevated |
DDOG has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
DDOG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 16.7 | Oversold |
DDOG's weekly RSI is 43 (neutral) and its Stochastic is 17 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over DDOG on valuation relative to its sector.
DDOG PE vs Technology Sector
| Metric | DDOG | Sector median | Relative |
|---|---|---|---|
| PE | 256x | 28x | 820% above |
| PE % | 19 | 35 | 16 pts below |
DDOG is trading at 256x earnings, a 820% premium to the Technology sector's median of 28x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
DDOG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $244.3 | 24% below |
| 20 week MA | $243.6 | 24% below |
| 50 week MA | $189.3 | 2.6% below |
| 100 week MA | $161.1 | 14% above |
| 200 week MA | $134.5 | 37% above |
DDOG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
DDOG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.1 | $106.3 | +194% |
| 2021 | $106.3 | $180.4 | +70% |
| 2022 | $180.4 | $72.4 | -60% |
| 2023 | $72.4 | $121.4 | +68% |
| 2024 | $121.4 | $146.0 | +20% |
| 2025 | $146.0 | $138.3 | -5.3% |
| 2026 YTD | $138.3 | $184.5 | +33% |
DDOG has the edge over BAC on returns for 2026, with the stronger performance.